Gilead Sciences (Brazil) Today
| GILD34 Stock | BRL 173.50 3.80 2.14% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Gilead Sciences is trading at 173.50 as of the 19th of April 2024, a -2.14 percent decrease since the beginning of the trading day. The stock's open price was 177.3. Gilead Sciences has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Gilead Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company was founded in 1987 and is headquartered in Foster City, California. The company has 2.49 B outstanding shares. More on Gilead Sciences
Moving together with Gilead Stock
| 0.69 | BIIB34 | Biogen Inc | PairCorr |
Moving against Gilead Stock
| 0.82 | TMCO34 | Toyota Motor | PairCorr |
| 0.8 | TSMC34 | Taiwan Semiconductor | PairCorr |
| 0.78 | HOND34 | Honda Motor | PairCorr |
| 0.76 | MRCK34 | Merck | PairCorr |
| 0.7 | NMRH34 | Nomura Holdings | PairCorr |
| 0.67 | ABBV34 | AbbVie Inc | PairCorr |
| 0.66 | B1SA34 | Banco Santander Chile | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Gilead Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Gilead Sciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Gilead Sciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | John Milligan |
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Gilead Sciences (GILD34) is traded on Sao Paulo Exchange in Brazil and employs 31 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 572.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Gilead Sciences's market, we take the total number of its shares issued and multiply it by Gilead Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Gilead Sciences operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 2.49 B outstanding shares.
Gilead Sciences has accumulated about 28.36 B in cash with 9.07 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 22.39.
Check Gilead Sciences Probability Of Bankruptcy
Gilead Stock Price Odds Analysis
What are Gilead Sciences' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Gilead Sciences jumping above the current price in 90 days from now is about 88.8%. The Gilead Sciences probability density function shows the probability of Gilead Sciences stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Gilead Sciences has a beta of -0.0647. This usually indicates as returns on the benchmark increase, returns on holding Gilead Sciences are expected to decrease at a much lower rate. During a bear market, however, Gilead Sciences is likely to outperform the market. Additionally, gilead Sciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Gilead Sciences to move above the current price in 90 days from now is about 88.8 (This Gilead Sciences probability density function shows the probability of Gilead Stock to fall within a particular range of prices over 90 days) .
Gilead Sciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Gilead Sciences market risk premium is the additional return an investor will receive from holding Gilead Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Gilead Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Gilead Sciences' alpha and beta are two of the key measurements used to evaluate Gilead Sciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.807 | |||
| Standard Deviation | 1.37 | |||
| Variance | 1.86 | |||
| Risk Adjusted Performance | (0.12) |
Gilead Stock Against Markets
Picking the right benchmark for Gilead Sciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Gilead Sciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Gilead Sciences is critical whether you are bullish or bearish towards Gilead Sciences at a given time. Please also check how Gilead Sciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Gilead Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Gilead Sciences Corporate Directors
Gilead Sciences corporate directors refer to members of a Gilead Sciences board of directors. The board of directors generally takes responsibility for the Gilead Sciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Gilead Sciences' board members must vote for the resolution. The Gilead Sciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gayle Wilson | Independent Director | Profile | |
| Jacqueline Barton | Director | Profile | |
| Kevin Lofton | Independent Director | Profile | |
| John Cogan | Lead Independent Director | Profile |
How to buy Gilead Stock?
Before investing in Gilead Sciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Gilead Sciences. To buy Gilead Sciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Gilead Sciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Gilead Sciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Gilead Sciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Gilead Sciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Gilead Sciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Gilead Stock please use our How to Invest in Gilead Sciences guide.
Already Invested in Gilead Sciences?
The danger of trading Gilead Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Gilead Sciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Gilead Sciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Gilead Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.Note that the Gilead Sciences information on this page should be used as a complementary analysis to other Gilead Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |